Deciphera Pharmaceuticals, a Waltham cancer biotech, said Monday it will be bought by Ono Pharmaceutical for $2.4 billon to ...

Prosecutors are probing McKinsey's role in advising opioid drugmakers. The opioid crisis has killed hundreds of thousands of ...

California is partnering with a New Jersey-based pharmaceutical company to purchase a generic version of Narcan, the most ...

Businessman and TV personality Mark Cuban has a seemingly straightforward question for the huge drug middleman owned by CVS: ...

China has been fueling the deadly fentanyl crisis ravaging communities across the US via subsidies of key precursor chemicals ...

After years of effort, delays and hundreds of millions of dollars of billionaire Patrick Soon-Shiong’s own money, last week ...

Investments in drug research and development are paying dividends while the cost to do so stays flat, a trend that appears to ...

Minnesotans, with their long-valued sense of fairness and decency, would never suggest that Fortune 500 corporations should ...

The U.S. is set to see a surge in obesity drug introductions over the next five years. Here’s a rundown of the potential ...

Analyst Chris Li CFA from Desjardins maintained a Hold rating on Loblaw Companies (LBLCF – Research Report) and increased the price ...

Nine months into the U.S. launch of the first drug proven to slow the advance of Alzheimer's, Eisai and Biogen's Leqembi is ...

Yahoo Sports' Charles McDonald breaks down the Broncos' 2024 draft. Not everyone was thrilled with their team's draft on ...